Publication Date:
2015
Citation:
Surgical site infections in oncologic orthopaedic prosthetics surgery / M. Nobile, P. Navone, G. Domeniconi, A. Della Valle, P.A. Daolio, N.A. Buccino, F. Auxilia. - In: ANNALI DI IGIENE MEDICINA PREVENTIVA E DI COMUNITÀ. - ISSN 1120-9135. - 27:5(2015), pp. 711-717.
abstract:
Background
Literature reports an incidence of surgical site infections (SSIs) in oncological patients undergoing prosthetic replacement between 8% and 35% after first implantation and 43% after revision. The purpose of this retrospective study, conducted at the oncologic orthopaedic unit of G. Pini Orthopaedic Hospital in Milan, was to evaluate:
- number of SSIs in oncological megaprosthetic reconstruction between 2008 and 2011,
- possible risk factors associated with the onset of SSIs,
- antibiotic prophylaxis applied.
Design and Methods
We reviewed medical records of patients who underwent megaprosthetic reconstruction and collected data on whole treatment and follow up after discharge, focusing on possible risk factors implied in the onset of SSIs such as patient characteristics, site of surgery, duration of surgery, number of persons in the operating room, size of resection, antibiotic prophylaxis. We recorded every SSI which met the
criteria set by the Hospital in Europe Link for Infection Control through Surveillance (HELICS) protocol.
Results
One-hundred and eleven surgeries were evaluated. Administration of prophylaxis was generally recorded and continued postoperatively for an average of 18.89 days, often depending on the length of the post-surgical stay. Mean duration of surgery was 254 minutes with an average of 7 persons attending the operating room. We recorded 6 SSIs.
Literature reports an incidence of surgical site infections (SSIs) in oncological patients undergoing prosthetic replacement between 8% and 35% after first implantation and 43% after revision. The purpose of this retrospective study, conducted at the oncologic orthopaedic unit of G. Pini Orthopaedic Hospital in Milan, was to evaluate:
- number of SSIs in oncological megaprosthetic reconstruction between 2008 and 2011,
- possible risk factors associated with the onset of SSIs,
- antibiotic prophylaxis applied.
Design and Methods
We reviewed medical records of patients who underwent megaprosthetic reconstruction and collected data on whole treatment and follow up after discharge, focusing on possible risk factors implied in the onset of SSIs such as patient characteristics, site of surgery, duration of surgery, number of persons in the operating room, size of resection, antibiotic prophylaxis. We recorded every SSI which met the
criteria set by the Hospital in Europe Link for Infection Control through Surveillance (HELICS) protocol.
Results
One-hundred and eleven surgeries were evaluated. Administration of prophylaxis was generally recorded and continued postoperatively for an average of 18.89 days, often depending on the length of the post-surgical stay. Mean duration of surgery was 254 minutes with an average of 7 persons attending the operating room. We recorded 6 SSIs.
IRIS type:
01 - Articolo su periodico
Keywords:
endoprosthesis; orthopaedic oncology; surgical site infection
List of contributors:
M. Nobile, P. Navone, G. Domeniconi, A. Della Valle, P.A. Daolio, N.A. Buccino, F. Auxilia
Link to information sheet: